Research Papers

25 of 425 papers

CSV Excel
Quick filters: Open Data Open Code Pre-registered Funding Declared COI Declared Open Access Clear Filters
<i>Akkermansia muciniphila</i> and <i>Bifidobacterium bifidum</i> Prevent NAFLD by Regulating FXR Expression and Gut Mi…
Nian F; Wu L; Xia Q; Tian P; Ding C; Lu X.
J Clin Transl Hepatol (Unknown)
Published: 2023
4/6 Transparent
Data Funding Declared
Primary Non-HFE Hemochromatosis: A Review.
Turshudzhyan A; Wu DC; Wu GY.
J Clin Transl Hepatol (Unknown)
Published: 2023
2/6 Transparent
Double Plasma Molecular Adsorption System with Sequential Low-dose Plasma Exchange in Patients with Hepatitis B Virus-r…
Wang L; Xu W; Zhu S; Lin G; Lai J; Zhang Y; Liu Y; Zheng L; Luo Q; Gao Z; Xie C; Peng L.
J Clin Transl Hepatol (Unknown)
Published: 2023
4/6 Transparent
Registered Funding Declared
Emerging Therapeutic Strategies in The Fight Against Primary Biliary Cholangitis.
Medford A; Childs J; Little A; Chakraborty S; Baiocchi L; Alpini G; Glaser S.
J Clin Transl Hepatol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Cardiac Syndromes in Liver Disease: A Clinical Conundrum.
Brankovic M; Lee P; Pyrsopoulos N; Klapholz M.
J Clin Transl Hepatol (Unknown)
Published: 2023
2/6 Transparent
Vaginal Delivery and Breastfeeding Benefit Infant Immune Response to Hepatitis B Vaccine: A Prospective Cohort Study.
Liu H; Li L; Li Y; Liu M; Song Y; Ding F; Zhang X; Li J.
J Clin Transl Hepatol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
R0 Liver Resection should be a First-line Treatment for Selected Patients with Intermediate Hepatocellular Cancer.
Janicko M; Drazilova S; Jarcuska P.
J Clin Transl Hepatol (Unknown)
Published: 2023
2/6 Transparent
Impact of <i>Helicobacter pylori</i> Infection on the Pathogenesis and Management of Nonalcoholic Fatty Liver Disease.
Mavilia-Scranton MG; Wu GY; Dharan M.
J Clin Transl Hepatol (Unknown)
Published: 2023
2/6 Transparent
Defining the Value of Extracorporeal Liver Support in Acute and Acute-on-chronic Liver Failure.
van Hoek B.
J Clin Transl Hepatol (Unknown)
Published: 2023
2/6 Transparent
Breath Biopsy<sup>®</sup> to Identify Exhaled Volatile Organic Compounds Biomarkers for Liver Cirrhosis Detection.
Ferrandino G; De Palo G; Murgia A; Birch O; Tawfike A; Smith R; Debiram-Beecham I; Gandelman O; Kibble G; Lydon AM; Groves A; Smolinska A; Allsworth M; Boyle B; van der Schee MP; Allison M; Fitzgerald RC; Hoare M; Snowdon VK.
J Clin Transl Hepatol (Unknown)
Published: 2023
4/6 Transparent
Data Funding Declared
Augmenter of Liver Regeneration Monoclonal Antibody Promotes Apoptosis of Hepatocellular Carcinoma Cells.
Huang LL; Luo FY; Huang WQ; Guo H; Liu Q; Zhang L; Jin AS; Sun H.
J Clin Transl Hepatol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
STX5 Inhibits Hepatocellular Carcinoma Adhesion and Promotes Metastasis by Regulating the PI3K/mTOR Pathway.
Zhang B; Zhao Z; Wang Y; Guo T; He M; Guan G; Peng P; Cai J; Zhang B; Liu X; Song Q.
J Clin Transl Hepatol (Unknown)
Published: 2023
2/6 Transparent
New Algorithm Rules Out Acute-on-chronic Liver Failure Development within 28 Days from Acute Decompensation of Cirrhosi…
Tang X; Li H; Deng G; Zheng X; Wang X; Huang Y; Gao Y; Meng Z; Qian Z; Liu F; Lu X; Shi Y; Li B; Gu W; Xiang X; Xiong Y; Hou Y; Chen J; Gao N; Luo S; Ji L; Li J; Zheng R; Ren H; Chen J.
J Clin Transl Hepatol (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
96-Week Treatment of Tenofovir Amibufenamide and Tenofovir Disoproxil Fumarate in Chronic Hepatitis B Patients.
Liu Z; Jin Q; Zhang Y; Gong G; Wu G; Yao L; Wen X; Gao Z; Huang Y; Yang D; Chen E; Mao Q; Lin S; Shang J; Gong H; Zhong L; Yin H; Wang F; Hu P; Wu Q; Pan C; Jia W; Li C; Sun C; Niu J; Hou J; TMF Study Group.
J Clin Transl Hepatol (Unknown)
Published: 2022
4/6 Transparent
Registered Funding Declared
Fas/FasL and Complement Activation are Associated with Chronic Active Epstein-Barr Virus Hepatitis.
Lin J; Su MF; Zheng JL; Gu L; Wu HC; Wu X; Lin HY; Wu ZX; Li DL.
J Clin Transl Hepatol (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Post-hepatoportoenterostomy Acoustic Radiation Force Impulse Elastography to Predict Two-year Outcome of Biliary Atresi…
Zhao D; Li Y; Xie W; Wu W; Chen Y; Zhang Y.
J Clin Transl Hepatol (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Hepatic Alarmins and Mitochondrial Dysfunction under Residual Hyperlipidemic Stress Lead to Irreversible NAFLD.
Ivan L; Uyy E; Suica VI; Boteanu RM; Cerveanu-Hogas A; Hansen R; Antohe F.
J Clin Transl Hepatol (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Reduction in Intrahepatic cccDNA and Integration of HBV in Chronic Hepatitis B Patients with a Functional Cure.
Gan W; Gao N; Gu L; Mo Z; Pang X; Lei Z; Gao Z.
J Clin Transl Hepatol (Unknown)
Published: 2022
2/6 Transparent
New Staging Model for Radiation-based Hepatocellular Carcinoma Treatment: A National Multicenter Study.
Su TS; Liang SX; Li LQ; Liu QH; Duan XZ; Sun J; Zeng H; Zhu HS; Li JX; Zhu XF; Zhuang HQ; Liang P; Huang Y.
J Clin Transl Hepatol (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Combination Therapies for Advanced Biliary Tract Cancer.
Zeng W; Mao R; Zhang Z; Chen X.
J Clin Transl Hepatol (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Role of Transarterial Chemoembolization in the Treatment of Hepatocellular Carcinoma.
Zhong BY; Jin ZC; Chen JJ; Zhu HD; Zhu XL.
J Clin Transl Hepatol (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Time of Liver Function Abnormal Identification on Prediction of the Risk of Anti-tuberculosis-induced Liver Injury.
Huang D; Peng J; Lei L; Chen Y; Zhu Z; Cai Q; Deng Y; Chen J.
J Clin Transl Hepatol (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Establishment of a Rat Model of Liver Venous Deprivation: Simultaneous Portal and Hepatic Vein Ligation.
Zhang Y; He X; Ma P; Xiong L; Bai W; Zhang G; Xu Y; Song W; Yu K.
J Clin Transl Hepatol (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Peptidomic Analysis Reveals that Novel Peptide LDP2 Protects Against Hepatic Ischemia/Reperfusion Injury.
Bao Q; Wang Z; Cheng S; Zhang J; Liu Q; Zhang Y; Cheng D; Guo X; Wang X; Han B; Sun P.
J Clin Transl Hepatol (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Nonalcoholic Fatty Liver Disease in Lean/Nonobese and Obese Individuals: A Comprehensive Review on Prevalence, Pathogen…
Patel AH; Peddu D; Amin S; Elsaid MI; Minacapelli CD; Chandler TM; Catalano C; Rustgi VK.
J Clin Transl Hepatol (Unknown)
Published: 2022
2/6 Transparent